- Home
- VALN vs CSR Comparison
VALN vs CSR Comparison
Compare VALN & CSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VALN
- CSR
- Stock Information
- Founded
- VALN 2012
- CSR 1970
- Country
- VALN France
- CSR United States
- Employees
- VALN N/A
- CSR N/A
- Industry
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- CSR Real Estate Investment Trusts
- Sector
- VALN Health Care
- CSR Real Estate
- Exchange
- VALN Nasdaq
- CSR Nasdaq
- Market Cap
- VALN 820.0M
- CSR 965.4M
- IPO Year
- VALN 2021
- CSR N/A
- Fundamental
- Price
- VALN $8.74
- CSR $59.84
- Analyst Decision
- VALN Strong Buy
- CSR Buy
- Analyst Count
- VALN 4
- CSR 7
- Target Price
- VALN $15.75
- CSR $68.57
- AVG Volume (30 Days)
- VALN 26.9K
- CSR 130.4K
- Earning Date
- VALN 11-20-2025
- CSR 11-03-2025
- Dividend Yield
- VALN N/A
- CSR 5.10%
- EPS Growth
- VALN N/A
- CSR N/A
- EPS
- VALN N/A
- CSR 1.82
- Revenue
- VALN $230,566,060.00
- CSR $273,450,000.00
- Revenue This Year
- VALN $6.86
- CSR $5.77
- Revenue Next Year
- VALN $11.85
- CSR $1.53
- P/E Ratio
- VALN N/A
- CSR $32.80
- Revenue Growth
- VALN 25.47
- CSR 5.72
- 52 Week Low
- VALN $3.62
- CSR $52.76
- 52 Week High
- VALN $12.25
- CSR $75.92
- Technical
- Relative Strength Index (RSI)
- VALN 32.81
- CSR 52.89
- Support Level
- VALN $9.01
- CSR $58.01
- Resistance Level
- VALN $9.28
- CSR $60.87
- Average True Range (ATR)
- VALN 0.21
- CSR 1.31
- MACD
- VALN -0.11
- CSR -0.04
- Stochastic Oscillator
- VALN 0.00
- CSR 56.13
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.
About CSR D/B/A Centerspace
Centerspace is a real estate investment trust (REIT) that focuses on the ownership, management, acquisitions, redevelopment, and development of apartment communities. The company operates through a single reportable segment which includes the ownership, management, development, redevelopment, and acquisition of apartment communities and conduct their corporate operations from offices in Minot, North Dakota and Minneapolis, Minnesota.